• Je něco špatně v tomto záznamu ?

Probiotic characteristics of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum

U. Bagci, S. Ozmen Togay, A. Temiz, M. Ay,

. 2019 ; 64 (6) : 735-750. [pub] 20190209

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20008036

Grantová podpora
4753 Hacettepe ?niversitesi

As potential probiotic traits of human milk-isolated bacteria have increasingly been recognized, this study aimed to evaluate the probiotic properties of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum. Among 118 human milk- and colostrum-isolated lactic cocci, only 29 were identified as Enterococcus. Of these, only four Enterococcus faecium isolates exhibited bacteriocigenic activity against several pathogenic Gram-positive bacteria, including Listeria monocytogenes. These isolates exhibited high acid (up to pH 3.0) and bile tolerance (0.5% oxgall) in simulated gastrointestinal conditions, demonstrating their ability to survive through the upper gastrointestinal tract. All of the E. faecium strains were shown to be sensitive to most of the antibiotics including vancomycin, tetracycline, rifampicin, and erythromycin, while they were resistant to kanamycin and chloramphenicol. None of the strains showed any virulence (gelE, agg2, clyA, clyB, clyM) and antibiotic resistance genes (vanA, vanB, ermB, tetM, and aac(6')-le-aph(2″)-la). In addition, all the strains were able to assimilate cholesterol, ranging between 25.2-64.1% and they exhibited variable adherence (19-36%) to Caco-2 cells. Based on the overall results of this in vitro study, four of the E. faecium strains isolated from human milk and colostrum can be considered as promising probiotic candidates; however, further in vivo evaluations are required.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20008036
003      
CZ-PrNML
005      
20200605112933.0
007      
ta
008      
200605s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-019-00687-2 $2 doi
035    __
$a (PubMed)30739237
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bagci, Ufuk $u Department of Food Engineering, Faculty of Engineering, Trakya University, 22180, Edirne, Turkey. ufukbagci@gmail.com.
245    10
$a Probiotic characteristics of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum / $c U. Bagci, S. Ozmen Togay, A. Temiz, M. Ay,
520    9_
$a As potential probiotic traits of human milk-isolated bacteria have increasingly been recognized, this study aimed to evaluate the probiotic properties of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum. Among 118 human milk- and colostrum-isolated lactic cocci, only 29 were identified as Enterococcus. Of these, only four Enterococcus faecium isolates exhibited bacteriocigenic activity against several pathogenic Gram-positive bacteria, including Listeria monocytogenes. These isolates exhibited high acid (up to pH 3.0) and bile tolerance (0.5% oxgall) in simulated gastrointestinal conditions, demonstrating their ability to survive through the upper gastrointestinal tract. All of the E. faecium strains were shown to be sensitive to most of the antibiotics including vancomycin, tetracycline, rifampicin, and erythromycin, while they were resistant to kanamycin and chloramphenicol. None of the strains showed any virulence (gelE, agg2, clyA, clyB, clyM) and antibiotic resistance genes (vanA, vanB, ermB, tetM, and aac(6')-le-aph(2″)-la). In addition, all the strains were able to assimilate cholesterol, ranging between 25.2-64.1% and they exhibited variable adherence (19-36%) to Caco-2 cells. Based on the overall results of this in vitro study, four of the E. faecium strains isolated from human milk and colostrum can be considered as promising probiotic candidates; however, further in vivo evaluations are required.
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a antibióza $7 D000898
650    _2
$a bakteriální adheze $7 D001422
650    _2
$a bakteriociny $x metabolismus $7 D001430
650    _2
$a žlučové kyseliny a soli $x farmakologie $7 D001647
650    _2
$a Caco-2 buňky $7 D018938
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a kolostrum $x mikrobiologie $7 D003126
650    _2
$a bakteriální léková rezistence $7 D024881
650    _2
$a Enterococcus faecium $x účinky léků $x genetika $x izolace a purifikace $x metabolismus $7 D016984
650    _2
$a žaludeční šťáva $7 D005750
650    _2
$a lidé $7 D006801
650    _2
$a Listeria monocytogenes $x fyziologie $7 D008089
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a mateřské mléko $x mikrobiologie $7 D008895
650    12
$a probiotika $7 D019936
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ozmen Togay, Sine $u Department of Food Engineering, Uludag University, Bursa, Turkey.
700    1_
$a Temiz, Ayhan $u Department of Food Engineering, Hacettepe University, Ankara, Turkey.
700    1_
$a Ay, Mustafa $u Department of Food Technology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 6 (2019), s. 735-750
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30739237 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20200605 $b ABA008
991    __
$a 20200605112931 $b ABA008
999    __
$a ok $b bmc $g 1531679 $s 1098109
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 64 $c 6 $d 735-750 $e 20190209 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a 4753 $p Hacettepe ?niversitesi
LZP    __
$a Pubmed-20200605

Najít záznam

Citační ukazatele

Možnosti archivace